Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation

Table 2

Procedural adverse clinical outcomes stratified by the presence of concomitant coronary artery disease (CAD).

	Whole population	CAD group	No CAD group	value CAD versus no CAD
	N = 1030	N = 372	N = 658
Death, N(%)	28 (2.7)	11 (3)	17 (2.6)	0.72
Significant complications, N(%)
Major or life-threatening bleeding	29 (2.8)	14 (3.8)	15 (2.3)	0.16
Minor bleeding	37 (3.6)	14 (3.8)	23 (3.5)	0.82
Major vascular complication	40 (3.9)	17 (4.6)	23 (3.5)	0.39
Minor vascular complication	77 (7.5)	25 (6.7)	52 (7.9)	0.48
Stroke	25 (2.4)	9 (2.4)	16 (2.4)	0.99
Acute kidney injury	28 (2.7)	8 (2.2)	20 (3)	0.39
Pacemaker implantation	129 (12.5)	51 (13.7)	78 (11.9)	0.38
CCU admission, N(%)	567 (55)	212 (57)	355 (54)	0.34